Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on ...

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.

Prior to that, 23andMe’s independent directors—Roelof Botha, Patrick Chung, Sandra Hernández, Neal Mohan, Valerie Montgomery ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...

October 31, 2024 00:00 AM UTC - Updated October 31, 2024 19:40 PM UTC 23andMe appoints three former CFOs as new ...